Floatz logo

29 assets in Fallopian Tube Serous Adenocarcinoma

Therapeutic assets addressing Fallopian Tube Serous Adenocarcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Carboplatin
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P3BBB (72)
Olaparib
Fallopian Tube Serous Adenocarcinoma
NRG OncologyP3BBB (72)
Cis-Diamminedichloroplatinum Ii
Fallopian Tube Serous Adenocarcinoma
Ohio State University Comprehensive Cancer CenterP3BB (68)
Adriamycin
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P2/3BB (67)
Cediranib
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P2/3BB (66)
Cyclophosphamide
Fallopian Tube Serous Adenocarcinoma
Roswell Park Cancer InstituteP2BB (66)
Nogitecan
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P3BB (66)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine
Fallopian Tube Serous Adenocarcinoma
Mayo ClinicP2BB (65)
Pembrolizumab
Fallopian Tube Serous Adenocarcinoma
Roswell Park Cancer InstituteP2B (63)
Docetaxel
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P3B (60)
Letrozole
Fallopian Tube Serous Adenocarcinoma
NRG OncologyP3B (60)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Fallopian Tube Serous Adenocarcinoma
Mayo ClinicP2B (59)
Atezolizumab
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P2/3B (57)
Adsorbed Purified Pertussis Vaccine
Fallopian Tube Serous Adenocarcinoma
Mayo ClinicP2CCC (53)
Anetumab Ravtansine
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Diphtheria Toxoid
Fallopian Tube Serous Adenocarcinoma
Mayo ClinicP2CCC (53)
Diphtheria Toxoid Adsorbed
Fallopian Tube Serous Adenocarcinoma
Mayo ClinicP2CCC (53)
Durvalumab
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Lenvatinib
Fallopian Tube Serous Adenocarcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Pegcetacoplan
Fallopian Tube Serous Adenocarcinoma
Roswell Park Cancer InstituteP2CCC (53)
Tetanus Toxoid
Fallopian Tube Serous Adenocarcinoma
Mayo ClinicP2CCC (53)
Cdx 1140
Fallopian Tube Serous Adenocarcinoma
Roswell Park Cancer InstituteP2CCC (51)
Oregovamab
Fallopian Tube Serous Adenocarcinoma
CanariaBio Inc.P3CCC (51)
Copanlisib
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (49)
Tolinapant
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P1/2CC (47)
Elimusertib
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P1CC (43)
Ipatasertib
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P1CC (43)
Adavosertib
Fallopian Tube Serous Adenocarcinoma
M.D. Anderson Cancer CenterEarly P1C (39)